Business
FDA Allows PTX IND for Leukemia Phase Ib & II Trials
FDA Allows PTX IND for Leukemia Phase Ib & II Trials
About this update from Prescient Therapeutics Limited
[{"type":"text","content":"Prescient Therapeutics Limited has released a press release. View Attachment","length":258,"tagName":"div"}]